Postday One-step Tablet
FDA Label NDC 69953-618

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Rapha Pharmaceuticals, Inc. for the product Postday One-step (NDC 69953-618). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug facts, purpose, use, warnings, do not use, ask a doctor or pharmacist before use if you are, when using this product you may have, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.